menu
    • menu

    Company profile for Concerto Biosciences

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Concerto Biosciences reinvents humanity’s relationship with microbes. We envision a future where each of us fine-tunes the microbial communities in us, on us, and around us to stay healthy. To pave the way, Concerto invented a platform to measure, in ultra-high throughput, how microbes behave in the presence of each other. These measurements enable Concerto to see the world as it is: a massive underlying network of microbial...
    Concerto Biosciences reinvents humanity’s relationship with microbes. We envision a future where each of us fine-tunes the microbial communities in us, on us, and around us to stay healthy. To pave the way, Concerto invented a platform to measure, in ultra-high throughput, how microbes behave in the presence of each other. These measurements enable Concerto to see the world as it is: a massive underlying network of microbial interactions that shapes the health of our bodies and our planet. The network reveals new products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Concerto BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge, MA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.concertobio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/concerto-biosciences/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Concerto Downsizes Amid Pivot to Consumer
    Concerto Downsizes Amid Pivot to Consumer

    17 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2026

    FIERCE BIOTECH
    17 Feb 2026
    Share Share
    Concerto Biosciences Inks Microbial Deal with Sacco System
    Concerto Biosciences Inks Microbial Deal with Sacco System

    29 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/concerto-biosciences-signs-development-and-commercialization-agreement-with-sacco-system-to-advance-next-generation-microbial-ingredient-discovery-302673813.html

    PR NEWSWIRE
    29 Jan 2026
    Share Share
    Concerto Biosciences Reports Phase 1B Trial Success For ENS-002
    Concerto Biosciences Reports Phase 1B Trial Success For ENS-002

    28 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/concerto-biosciences-announces-positive-topline-results-from-phase-1b-clinical-trial-of-ens-002-in-patients-with-atopic-dermatitis-302596913.html

    PR NEWSWIRE
    28 Oct 2025
    Share Share
    Concerto Biosciences Gets FDA Clearance For Atopic Dermatitis Treatment
    Concerto Biosciences Gets FDA Clearance For Atopic Dermatitis Treatment

    26 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/concerto-biosciences-receives-fda-investigational-new-drug-clearance-for-live-biotherapeutic-product-to-treat-atopic-dermatitis-302183090.html

    PR NEWSWIRE
    26 Jun 2024
    Share Share
    Concerto Biosciences Announces Strategic Business Development Hire
    Concerto Biosciences Announces Strategic Business Development Hire

    06 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230206005108/en

    BUSINESSWIRE
    06 Feb 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search